CLH(CLH)
CLH
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $6.52B | $6.81B | $7.07B | $7.70B | $8.06B |
| Low | $6.30B | $6.59B | $6.79B | $7.45B | $7.81B |
| High | $6.61B | $6.97B | $7.28B | $7.85B | $8.23B |
| EBITDA Avg | $1.32B | $1.38B | $1.43B | $1.55B | $1.63B |
| Low | $1.27B | $1.33B | $1.37B | $1.51B | $1.58B |
| High | $1.33B | $1.41B | $1.47B | $1.59B | $1.66B |
| EBIT Avg | $851M | $890M | $924M | $1.01B | $1.05B |
| Low | $824M | $860M | $887M | $974M | $1.02B |
| High | $863M | $911M | $951M | $1.03B | $1.07B |
| Net Income Avg | $519M | $526M | $584M | $688M | $760M |
| Low | $449M | $489M | $529M | $660M | $729M |
| High | $542M | $566M | $633M | $707M | $781M |
| EPS Avg | $9.66 | $9.84 | $11.11 | $12.89 | $14.24 |
| Low | $8.41 | $9.16 | $9.91 | $12.37 | $13.66 |
| High | $10.16 | $10.61 | $11.85 | $13.24 | $14.62 |
| Analysts (Rev / EPS) | 10 / 10 | 10 / 10 | 6 / 5 | 4 / 1 | 3 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $1.72B | $1.61B | $1.58B | $1.77B | $1.75B | $1.67B | $1.63B | $1.82B |
| Low | $1.64B | $1.58B | $1.52B | $1.71B | $1.69B | $1.62B | $1.57B | $1.76B |
| High | $1.76B | $1.65B | $1.68B | $1.89B | $1.87B | $1.79B | $1.74B | $1.95B |
| EBITDA Avg | $347M | $326M | $318M | $358M | $354M | $338M | $329M | $368M |
| Low | $330M | $320M | $307M | $345M | $342M | $326M | $317M | $355M |
| High | $355M | $334M | $340M | $382M | $378M | $361M | $351M | $393M |
| EBIT Avg | $224M | $211M | $206M | $232M | $229M | $219M | $213M | $238M |
| Low | $214M | $207M | $199M | $223M | $221M | $211M | $205M | $230M |
| High | $230M | $216M | $220M | $247M | $245M | $234M | $227M | $254M |
| Net Income Avg | $167M | $114M | $80M | $160M | $156M | $124M | $93M | $179M |
| Low | $136M | $105M | $77M | $153M | $149M | $118M | $89M | $171M |
| High | $185M | $126M | $87M | $174M | $170M | $135M | $102M | $195M |
| EPS Avg | $3.15 | $2.16 | $1.52 | $3.02 | $2.95 | $2.34 | $1.76 | $3.38 |
| Low | $2.56 | $1.98 | $1.45 | $2.88 | $2.81 | $2.23 | $1.68 | $3.22 |
| High | $3.49 | $2.38 | $1.65 | $3.29 | $3.21 | $2.54 | $1.92 | $3.68 |
| Analysts (Rev / EPS) | 9 / 9 | 9 / 9 | 7 / 6 | 4 / 3 | 4 / 3 | 7 / 6 | 7 / 8 | 3 / 4 |